Novartis Ag NVS
NYSE NVS
$156.88 +2.95 (+1.92%)
As of: Oct 22, 2026 · 10:47 AM EDT

Novartis Ag (NVS) Capital Leases (2019 - 2023)

Updated

Analysis

Novartis Ag (NVS) Capital Leases (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Vertex Pharmaceuticals 135.17 Bn 107.17 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 230.00 Mn
Dec 31, 2022 251.00 Mn
Dec 31, 2021 275.00 Mn
Dec 31, 2020 286.00 Mn
Dec 31, 2019 246.00 Mn
API Access

Novartis Ag Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=NVS&period=max&api_key=YOUR_API_KEY